According to Axogen's latest financial reports and stock price the company's current number of shares outstanding is 43,022,328. At the end of 2023 the company had 43,022,328 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 43.02 M | 1.9% |
2022 | 42.22 M | 1.82% |
2021 | 41.46 M | 3.43% |
2020 | 40.09 M | 1.54% |
2019 | 39.48 M | 1.91% |
2018 | 38.74 M | 14.48% |
2017 | 33.84 M | 3.92% |
2016 | 32.56 M | 8.83% |
2015 | 29.92 M | 71.34% |
2014 | 17.46 M | 21.97% |
2013 | 14.32 M | 28.96% |
2012 | 11.1 M | 738.09% |
2011 | 1.32 M | 11.25% |
2010 | 1.19 M | -72.24% |
2009 | 4.29 M | 0% |
2008 | 4.29 M | 2.75% |
2007 | 4.17 M | 0.64% |
2006 | 4.14 M | 0% |
2005 | 4.14 M | 3.16% |
2004 | 4.02 M | 1.4% |
2003 | 3.96 M | 0.21% |
2002 | 3.95 M | 1.08% |
2001 | 3.91 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Medtronic MDT | 1,329,700,000 | 2,990.72% | ๐ฎ๐ช Ireland |
Thermo Fisher Scientific TMO | 387,000,000 | 799.53% | ๐บ๐ธ USA |
Boston Scientific BSX | 1,468,400,000 | 3,313.11% | ๐บ๐ธ USA |